Product Description
Formulation (Per Vial)
10 mg ARA-290
Total Volume: 2 mL
Classification: Prescription Molecule – Free Medical Consultation Required
What Is ARA-290?
ARA-290 (cibinetide) is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to activate the Innate Repair Receptor (IRR) without stimulating red blood cell production.
Unlike traditional EPO, ARA-290 does not increase hematocrit or hemoglobin. Instead, it selectively targets inflammatory and neuroprotective pathways involved in nerve irritation, small fiber dysfunction, and chronic inflammatory pain states.
Originally developed for neuropathic and inflammatory conditions, ARA-290 works by modulating immune signaling, protecting small nerve fibers, and improving microvascular function.
This formulation is designed for subcutaneous use, offering systemic support for individuals dealing with neuropathic pain, CRPS, radiculopathy, autonomic instability, and chronic inflammatory syndromes.
Why ARA-290 Matters
Chronic neuropathic pain or burning sensations
Small fiber nerve dysfunction
CRPS or centralized pain syndromes
Radicular symptoms after spine injury
Post-surgical nerve irritation
Autonomic instability or inflammatory flares
Persistent pain despite structural treatment
🔬 Key Research-Based Mechanisms
🧠 Innate Repair Receptor Activation
ARA-290 binds to the EPOR–CD131 receptor complex (Innate Repair Receptor), triggering anti-inflammatory and tissue-protective signaling without erythropoietic effects.
📖 Brines et al., 2008
🔥 Cytokine Modulation
Reduces pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, helping quiet chronic neuroinflammation.
📖 Dahan et al., 2013
⚡ Small Fiber Nerve Protection
Demonstrates protective effects on small nerve fibers, improving neuropathic symptoms in inflammatory and metabolic neuropathies.
📖 Heij et al., 2012
🩸 Microvascular & Endothelial Support
Improves endothelial function and tissue perfusion, supporting recovery in inflammatory and ischemic microenvironments.
📖 Brines & Cerami, 2012
💉 Dosing Protocol (ARA-290 10mg)
Each order includes:
✅ 1 × 2 mL ARA-290 vial (10 mg total)
✅ Pre-measured bacteriostatic water
✅ Insulin syringes
✅ Alcohol swabs
✅ Printed dosing and storage guide
Daily Dose: 4 mg per day
Schedule: 5 days on / 2 days off
Route: Subcutaneous injection (abdomen or upper arm)
Cycle Length: 8 – 12 weeks depending on severity and response
📦 What’s Included With Every Order
✅ 1 × 2 mL ARA-290 10 mg vial
✅ Pre-measured bacteriostatic water
✅ Insulin syringes + alcohol swabs
✅ Printed dosing and storage instructions
✅ Optional clinical guidance from Arizona Sports Medicine
⚕️ Access & Clinical Guidance
Free telehealth consult required
Ships with all supplies and dosing guide
Optional support available through our clinical team
📧 Admin@Propeptides.com
📞 480-400-6225
Directions For Use
Formulation (Per Vial)
10 mg ARA-290
Total Volume: 2 mL
Classification: Prescription Molecule – Free Medical Consultation Required
What Is ARA-290?
ARA-290 (cibinetide) is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to activate the Innate Repair Receptor (IRR) without stimulating red blood cell production.
Unlike traditional EPO, ARA-290 does not increase hematocrit or hemoglobin. Instead, it selectively targets inflammatory and neuroprotective pathways involved in nerve irritation, small fiber dysfunction, and chronic inflammatory pain states.
Originally developed for neuropathic and inflammatory conditions, ARA-290 works by modulating immune signaling, protecting small nerve fibers, and improving microvascular function.
This formulation is designed for subcutaneous use, offering systemic support for individuals dealing with neuropathic pain, CRPS, radiculopathy, autonomic instability, and chronic inflammatory syndromes.
Why ARA-290 Matters
Chronic neuropathic pain or burning sensations
Small fiber nerve dysfunction
CRPS or centralized pain syndromes
Radicular symptoms after spine injury
Post-surgical nerve irritation
Autonomic instability or inflammatory flares
Persistent pain despite structural treatment
🔬 Key Research-Based Mechanisms
🧠 Innate Repair Receptor Activation
ARA-290 binds to the EPOR–CD131 receptor complex (Innate Repair Receptor), triggering anti-inflammatory and tissue-protective signaling without erythropoietic effects.
📖 Brines et al., 2008
🔥 Cytokine Modulation
Reduces pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, helping quiet chronic neuroinflammation.
📖 Dahan et al., 2013
⚡ Small Fiber Nerve Protection
Demonstrates protective effects on small nerve fibers, improving neuropathic symptoms in inflammatory and metabolic neuropathies.
📖 Heij et al., 2012
🩸 Microvascular & Endothelial Support
Improves endothelial function and tissue perfusion, supporting recovery in inflammatory and ischemic microenvironments.
📖 Brines & Cerami, 2012
💉 Dosing Protocol (ARA-290 10mg)
Each order includes:
✅ 1 × 2 mL ARA-290 vial (10 mg total)
✅ Pre-measured bacteriostatic water
✅ Insulin syringes
✅ Alcohol swabs
✅ Printed dosing and storage guide
Daily Dose: 4 mg per day
Schedule: 5 days on / 2 days off
Route: Subcutaneous injection (abdomen or upper arm)
Cycle Length: 8 – 12 weeks depending on severity and response
📦 What’s Included With Every Order
✅ 1 × 2 mL ARA-290 10 mg vial
✅ Pre-measured bacteriostatic water
✅ Insulin syringes + alcohol swabs
✅ Printed dosing and storage instructions
✅ Optional clinical guidance from Arizona Sports Medicine
⚕️ Access & Clinical Guidance
Free telehealth consult required
Ships with all supplies and dosing guide
Optional support available through our clinical team
📧 Admin@Propeptides.com
📞 480-400-6225
Ingredients
Formulation (Per Vial)
10 mg ARA-290
Total Volume: 2 mL
Classification: Prescription Molecule – Free Medical Consultation Required
What Is ARA-290?
ARA-290 (cibinetide) is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to activate the Innate Repair Receptor (IRR) without stimulating red blood cell production.
Unlike traditional EPO, ARA-290 does not increase hematocrit or hemoglobin. Instead, it selectively targets inflammatory and neuroprotective pathways involved in nerve irritation, small fiber dysfunction, and chronic inflammatory pain states.
Originally developed for neuropathic and inflammatory conditions, ARA-290 works by modulating immune signaling, protecting small nerve fibers, and improving microvascular function.
This formulation is designed for subcutaneous use, offering systemic support for individuals dealing with neuropathic pain, CRPS, radiculopathy, autonomic instability, and chronic inflammatory syndromes.
Why ARA-290 Matters
Chronic neuropathic pain or burning sensations
Small fiber nerve dysfunction
CRPS or centralized pain syndromes
Radicular symptoms after spine injury
Post-surgical nerve irritation
Autonomic instability or inflammatory flares
Persistent pain despite structural treatment
🔬 Key Research-Based Mechanisms
🧠 Innate Repair Receptor Activation
ARA-290 binds to the EPOR–CD131 receptor complex (Innate Repair Receptor), triggering anti-inflammatory and tissue-protective signaling without erythropoietic effects.
📖 Brines et al., 2008
🔥 Cytokine Modulation
Reduces pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, helping quiet chronic neuroinflammation.
📖 Dahan et al., 2013
⚡ Small Fiber Nerve Protection
Demonstrates protective effects on small nerve fibers, improving neuropathic symptoms in inflammatory and metabolic neuropathies.
📖 Heij et al., 2012
🩸 Microvascular & Endothelial Support
Improves endothelial function and tissue perfusion, supporting recovery in inflammatory and ischemic microenvironments.
📖 Brines & Cerami, 2012
💉 Dosing Protocol (ARA-290 10mg)
Each order includes:
✅ 1 × 2 mL ARA-290 vial (10 mg total)
✅ Pre-measured bacteriostatic water
✅ Insulin syringes
✅ Alcohol swabs
✅ Printed dosing and storage guide
Daily Dose: 4 mg per day
Schedule: 5 days on / 2 days off
Route: Subcutaneous injection (abdomen or upper arm)
Cycle Length: 8 – 12 weeks depending on severity and response
📦 What’s Included With Every Order
✅ 1 × 2 mL ARA-290 10 mg vial
✅ Pre-measured bacteriostatic water
✅ Insulin syringes + alcohol swabs
✅ Printed dosing and storage instructions
✅ Optional clinical guidance from Arizona Sports Medicine
⚕️ Access & Clinical Guidance
Free telehealth consult required
Ships with all supplies and dosing guide
Optional support available through our clinical team
📧 Admin@Propeptides.com
📞 480-400-6225
Disclaimer
Formulation (Per Vial)
10 mg ARA-290
Total Volume: 2 mL
Classification: Prescription Molecule – Free Medical Consultation Required
What Is ARA-290?
ARA-290 (cibinetide) is a synthetic peptide derived from erythropoietin (EPO), specifically engineered to activate the Innate Repair Receptor (IRR) without stimulating red blood cell production.
Unlike traditional EPO, ARA-290 does not increase hematocrit or hemoglobin. Instead, it selectively targets inflammatory and neuroprotective pathways involved in nerve irritation, small fiber dysfunction, and chronic inflammatory pain states.
Originally developed for neuropathic and inflammatory conditions, ARA-290 works by modulating immune signaling, protecting small nerve fibers, and improving microvascular function.
This formulation is designed for subcutaneous use, offering systemic support for individuals dealing with neuropathic pain, CRPS, radiculopathy, autonomic instability, and chronic inflammatory syndromes.
Why ARA-290 Matters
Chronic neuropathic pain or burning sensations
Small fiber nerve dysfunction
CRPS or centralized pain syndromes
Radicular symptoms after spine injury
Post-surgical nerve irritation
Autonomic instability or inflammatory flares
Persistent pain despite structural treatment
🔬 Key Research-Based Mechanisms
🧠 Innate Repair Receptor Activation
ARA-290 binds to the EPOR–CD131 receptor complex (Innate Repair Receptor), triggering anti-inflammatory and tissue-protective signaling without erythropoietic effects.
📖 Brines et al., 2008
🔥 Cytokine Modulation
Reduces pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6, helping quiet chronic neuroinflammation.
📖 Dahan et al., 2013
⚡ Small Fiber Nerve Protection
Demonstrates protective effects on small nerve fibers, improving neuropathic symptoms in inflammatory and metabolic neuropathies.
📖 Heij et al., 2012
🩸 Microvascular & Endothelial Support
Improves endothelial function and tissue perfusion, supporting recovery in inflammatory and ischemic microenvironments.
📖 Brines & Cerami, 2012
💉 Dosing Protocol (ARA-290 10mg)
Each order includes:
✅ 1 × 2 mL ARA-290 vial (10 mg total)
✅ Pre-measured bacteriostatic water
✅ Insulin syringes
✅ Alcohol swabs
✅ Printed dosing and storage guide
Daily Dose: 4 mg per day
Schedule: 5 days on / 2 days off
Route: Subcutaneous injection (abdomen or upper arm)
Cycle Length: 8 – 12 weeks depending on severity and response
📦 What’s Included With Every Order
✅ 1 × 2 mL ARA-290 10 mg vial
✅ Pre-measured bacteriostatic water
✅ Insulin syringes + alcohol swabs
✅ Printed dosing and storage instructions
✅ Optional clinical guidance from Arizona Sports Medicine
⚕️ Access & Clinical Guidance
Free telehealth consult required
Ships with all supplies and dosing guide
Optional support available through our clinical team
📧 Admin@Propeptides.com
📞 480-400-6225
